HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Y Ogura Selected Research

Therapeutics

2/2015Inhibition of choroidal fibrovascular membrane formation by new class of RNA interference therapeutic agent targeting periostin.
6/2013Impact of sarcopenia on survival in patients undergoing living donor liver transplantation.
1/2012Effect of maintenance therapy with low-dose peginterferon for recurrent hepatitis C after living donor liver transplantation.
8/2010Herpes simplex virus hepatitis after pediatric liver transplantation.
8/2010Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection.
5/2006Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
10/2001Monoclonal antibody-mediated drug targeting to choroidal neovascularization in the rat.
10/2000[Biological regulation of copper and selective removal of copper: therapy for Wilson disease and its molecular mechanism].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Y Ogura Research Topics

Disease

5Neoplasms (Cancer)
05/2006 - 02/2001
5Ischemia
09/2001 - 08/2000
4Uveitis
04/2003 - 09/2000
4Cytomegalovirus Retinitis
10/2001 - 02/2000
3Liver Cirrhosis (Hepatic Cirrhosis)
06/2018 - 03/2001
3Budd-Chiari Syndrome (Budd Chiari Syndrome)
09/2017 - 10/2006
3Fibrosis (Cirrhosis)
02/2015 - 03/2001
3Infections
08/2010 - 09/2001
3Neoplasm Metastasis (Metastasis)
05/2006 - 02/2001
3Choroidal Neovascularization
10/2001 - 09/2000
3Reperfusion Injury
09/2001 - 08/2000
2Liver Failure
11/2015 - 06/2003
2Pathologic Constriction (Stenosis)
10/2015 - 10/2006
2Inflammation (Inflammations)
06/2001 - 01/2000
2Macular Degeneration (Age-Related Maculopathy)
12/2000 - 09/2000
1Muscle Weakness
12/2016
1Hepatic Encephalopathy
11/2015
1Pressure Ulcer (Bedsore)
10/2015
1Suppuration
10/2015
1Conversion Disorder (Astasia Abasia)
07/2015
1Major Depressive Disorder (Major Depressive Disorders)
07/2015
1Substance-Related Disorders (Drug Abuse)
07/2015
1Panic Disorder (Panic Attack)
07/2015
1Mental Disorders (Mental Disorder)
07/2015
1Situs Inversus
06/2014
1Sarcopenia
06/2013
1Hypertrophy
02/2013
1Hepatitis C
01/2012
1Tumor Lysis Syndrome
08/2010
1Alagille Syndrome (Alagille-Watson Syndrome)
08/2010
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
08/2010
1Hepatitis
08/2010
1Liver Diseases (Liver Disease)
08/2010
1Thrombotic Microangiopathies
08/2010
1Epstein-Barr Virus Infections
08/2010
1Hashimoto's encephalitis
08/2010
1Thrombosis (Thrombus)
11/2009
1Hepatocellular Carcinoma (Hepatoma)
10/2009
1Hemorrhage
10/2006
1Biliary Atresia
10/2006
1Intestinal Perforation
10/2006
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2006
1Necrosis
11/2004
1Wounds and Injuries (Trauma)
11/2004
1Thymoma (Thymic Carcinoma)
05/2004
1End Stage Liver Disease
01/2004
1Myocarditis (Carditis)
02/2002
1Asphyxia (Suffocation)
02/2002
1Heart Injuries
02/2002
1Craniocerebral Trauma (Head Injury)
02/2002

Drug/Important Bio-Agent (IBA)

8Retinaldehyde (Retinal)IBA
09/2001 - 05/2000
5Proteins (Proteins, Gene)FDA Link
02/2013 - 03/2001
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2015 - 05/2000
3EndotoxinsIBA
04/2003 - 06/2001
3AntigensIBA
10/2001 - 07/2000
2InterferonsIBA
01/2012 - 08/2010
2DNA (Deoxyribonucleic Acid)IBA
08/2010 - 03/2001
2Antithrombin IIIIBA
11/2009 - 06/2001
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
05/2006 - 03/2001
2SelectinsIBA
04/2003 - 09/2000
2SKK 60060IBA
04/2003 - 09/2000
2Monoclonal AntibodiesIBA
10/2001 - 12/2000
2Acridine OrangeIBA
09/2001 - 07/2001
2Ganciclovir (Cytovene)FDA LinkGeneric
08/2001 - 08/2000
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2001 - 01/2000
2Pharmaceutical PreparationsIBA
08/2000 - 02/2000
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2018
1Biomarkers (Surrogate Marker)IBA
06/2018
1BilirubinIBA
11/2015
1Allopurinol (Remid)FDA LinkGeneric
11/2015
1Glutamine (L-Glutamine)FDA Link
10/2015
1Arginine (L-Arginine)FDA Link
10/2015
1Ribavirin (Virazole)FDA LinkGeneric
01/2012
1Immunoglobulins (Immunoglobulin)IBA
08/2010
1Tacrolimus (Prograf)FDA LinkGeneric
08/2010
1acarboxyprothrombin (PIVKA)IBA
10/2009
1GemcitabineFDA Link
05/2006
1Angiogenesis InhibitorsIBA
05/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2004
1Transforming Growth Factor beta1 (TGF beta 1)IBA
11/2004
1Interleukin-1alpha (Interleukin 1 alpha)IBA
11/2004
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2004
1LysophospholipidsIBA
11/2004
1KalininIBA
11/2004
1Transforming Growth Factor alpha (TGF-alpha)IBA
11/2004
1CytokinesIBA
11/2004
1Transforming Growth Factors (Transforming Growth Factor)IBA
11/2004
1Tetrodotoxin (Tetradotoxin)IBA
02/2002
1Methamphetamine (Desoxyn)FDA LinkGeneric
02/2002

Therapy/Procedure

19Liver Transplantation
06/2018 - 06/2003
8Therapeutics
02/2015 - 10/2000
5Ligation
09/2001 - 08/2000
2Stents
06/2011 - 10/2006
1Splenectomy
06/2018
1Transplantation
07/2015
1Transjugular Intrahepatic Portasystemic Shunt
06/2011
1Surgical Portasystemic Shunt (Portosystemic Shunt)
06/2011
1Hepatectomy
06/2011
1Laparotomy
10/2006
1Sternotomy
05/2004